ORLANDO, Fla. and DUBLIN, Jan. 26, 2015 /PRNewswire/ --

Dear Immune Therapeutics, Inc. (OTC-BB: IMUN) Shareholder:

I am writing today to update you on an important operational change.  ClearTrust, LLC, a leading stock transfer agent serving growth companies and community banks, has acquired all issuer accounts of Guardian Registrar & Transfer, Inc., our transfer agent.  As a result, ClearTrust is now Immune Therapeutics' transfer agent and shareholder support provider. 

This change includes the transfer of your directly held shares of Immune Therapeutics' common stock from Guardian Registrar & Transfer to ClearTrust's platform. There is no action required on your part for this transaction.

If you have any questions regarding your shares, please contact a ClearTrust specialist by telephone at (813) 235-4490 or email at inbox@ClearTrustTransfer.com.  If you need to send documents to ClearTrust, such documents can be emailed to the foregoing email address, faxed to (813) 388-4549 or mailed to 16540 Pointe Village Drive, Suite 210, Lutz, Florida 33558.     

Thank you for your continued support of Immune Therapeutics.

Sincerely,

Noreen Griffin
Chief Executive Officer

Contact: Dennis S. Dobson
President and CEO
Dobson Media Group and
International Investor Relations Services Inc.
203-258-0159
www.dobsonmediagroup.com

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/cleartrust-llc-is-immune-therapeutics-new-transfer-agent-and-support-provider-300025761.html

SOURCE Immune Therapeutics, Inc.